Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade.

Suwabe T, Furuyama Y, Kawakami A, Tsuchida T, Mitobe M, Yonezawa H, Katagiri T, Fuse K, Shibasaki Y, Ushiki T, Masuko M, Munakata W, Miyoshi H, Ohshima K, Sone H, Takizawa J

Open source

DOI: 10.3960/jslrt.26007
Published: 2026 Jul 30
Container: Journal of clinical and experimental hematopathology : JCEH
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3960/jslrt.26007,
  title = {Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade.},
  author = {Suwabe T and Furuyama Y and Kawakami A and Tsuchida T and Mitobe M and Yonezawa H and Katagiri T and Fuse K and Shibasaki Y and Ushiki T and Masuko M and Munakata W and Miyoshi H and Ohshima K and Sone H and Takizawa J},
  year = {2026},
  journal = {Journal of clinical and experimental hematopathology : JCEH},
  doi = {10.3960/jslrt.26007},
  url = {https://doi.org/10.3960/jslrt.26007}
}

RIS

TY  - JOUR
TI  - Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade.
AU  - Suwabe T
AU  - Furuyama Y
AU  - Kawakami A
AU  - Tsuchida T
AU  - Mitobe M
AU  - Yonezawa H
AU  - Katagiri T
AU  - Fuse K
AU  - Shibasaki Y
AU  - Ushiki T
AU  - Masuko M
AU  - Munakata W
AU  - Miyoshi H
AU  - Ohshima K
AU  - Sone H
AU  - Takizawa J
PY  - 2026
JO  - Journal of clinical and experimental hematopathology : JCEH
DO  - 10.3960/jslrt.26007
UR  - https://doi.org/10.3960/jslrt.26007
ER  -

APA

T, S., Y, F., A, K., T, T., M, M., H, Y., T, K., K, F., Y, S., T, U., M, M., W, M., H, M., K, O., H, S., & J, T. (2026). Allogeneic hematopoietic stem cell transplantation achieves complete response in refractory primary mediastinal large B-cell lymphoma after the failure of chemotherapy, CAR-T therapy, and PD-1 blockade.. Journal of clinical and experimental hematopathology : JCEH. https://doi.org/10.3960/jslrt.26007

Source records

pubmed · retrieved 2026-09-26T10:25:54.755Z